Ductal carcinoma in situ: Assessment of necrosis and nuclear morphology and their association with biological markers
- 1 August 1995
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 176 (4) , 333-341
- https://doi.org/10.1002/path.1711760404
Abstract
One hundred and five cases of pure ductal carcinoma in situ (DCIS) seen in the Guy's Hospital breast unit between 1975 and 1991 were reviewed. The presence and extent of necrosis and the degree of cytonuclear differentiation were assessed and the expression of p53 protein, cerbB2 protein, progesterone receptor, and a proliferation antigen KiS1, all factors reported to be of prognostic significance in invasive ductal carcinoma, was evaluated using immunohis-tochemical methods. A strong correlation was seen between the presence and extent of necrosis and the degree of cytonuclear differentiation and between both these morphological criteria and the biological markers as well as between the individual markers. The presence of extensive necrosis was associated with lack of cytonuclear differentiation and both were associated with a high proliferation rate, the presence of cerbB2 and p53 protein, and the absence of progesterone receptors. In cases with little or no necrosis, there was good nuclear differentiation and a strong correlation with the presence of progesterone receptor, absence of cerbB2 and p53 protein, and a low rate of proliferation.Keywords
This publication has 24 references indexed in Scilit:
- Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast CancerNew England Journal of Medicine, 1993
- Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast CancerJNCI Journal of the National Cancer Institute, 1993
- KiSl—A novel monoclonal antibody which recognizes proliferating cells: Evaluation of its relationship to prognosis in mammary carcinomaThe Journal of Pathology, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Immunohistochemical distribution of c‐erbB‐2 in in situ breast carcinoma—a detailed morphological analysisThe Journal of Pathology, 1990
- Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological studyHistopathology, 1989
- IN-SITU BREAST CANCER: THE EORTC CONSENSUS MEETINGThe Lancet, 1989
- Review: Steroid Receptors, Cellular Kinetics, and Lymph Node Status as Prognostic Factors in Breast CancerThe Lancet Healthy Longevity, 1988
- Cell kinetics of histologic variants ofin situ breast carcinomaBreast Cancer Research and Treatment, 1986
- Noninvasive Breast CarcinomaAnnals of Surgery, 1980